Ingredients: Analysis of active ingredients, intermediates, and excipients in pharmaceutical development and manufacturing - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Ingredients
Trends, market analysis, and market growth reports on pharmaceutical ingredient suppliers and manufacturers. Sourcing and supply of active pharmaceutical ingredients (APIs), intermediates, excipients.

Seeking Alternative Catalyst Solutions

June 2, 2014

Pharmaceutical Technology

Transition metal-containing catalysts are widely used in organic synthesis, but many are based on expensive, rare metals. Researchers are seeking more sustainable alternatives.

HPAPIs: Fast-growing Segment Presents Challenges and Opportunities

May 30, 2014

PTSM: Pharmaceutical Technology Sourcing and Management

Appropriate process design and engineering are critical for the production of small-molecule and biologic HPAPIs.

BPTF Warns FDA on Reduced API Manufacturer Inspections

May 29, 2014
PTSM: Pharmaceutical Technology Sourcing and Management

The Bulk Pharmaceuticals Task Force asks FDA to respond to concerns about reduction in API facility compliance inspections.

Scientific Advances in Cocrystals are Offset by Regulatory Uncertainty

May 2, 2014

Pharmaceutical Technology

Drug developers are taking a wait-and-see approach to the use of cocrystals.

Control Strategies for Synthetic Therapeutic Peptide APIs Part III: Manufacturing Process Considerations

May 2, 2014

Pharmaceutical Technology

USP's Therapeutic Peptides Expert Panel discusses manufacturing processes and impurity control for synthetic peptide APIs.

Appropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs

April 2, 2014

Pharmaceutical Technology

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.

Solid Dosage and Excipients

April 1, 2014

Review emerging trends in the formulation and manufacture of solid dosage drugs, as well as the role of excipients in enhancing the functionality of these drug forms.

Tabletting performance of sorbitol excipient

March 5, 2014

Tereos Syral has conducted a formulation study to assess the tableting performance of sorbitol excipient (spray-dried and crystalline) against lactose when associated with ascorbic acid at 25%. It shows that sorbitol ensures high quality while providing competitive advantages in terms of hardness, friability, colour stability, dilution potential and dissolution profile.

Synthetic Biology: The Next Frontier in Chiral Chemistry for API Synthesis

March 2, 2014

Pharmaceutical Technology

The commercial availability of an increasing diversity of enzymes has led to the growing use of biocatalysts for API synthesis.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What impact do mega-mergers of biopharmaceutical companies have on the development of new drugs?
Improves the quality and number of innovative drugs available to patients.
Restricts innovation and the development of new drugs.
Has no impact on drug development.
Do not know.
Improves the quality and number of innovative drugs available to patients.
29%
Restricts innovation and the development of new drugs.
54%
Has no impact on drug development.
4%
Do not know.
13%
Eric Langer Outsourcing Outlook Eric LangerOutsourcing No Longer Just for Cost-Cutting
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerSeeking Alternative Catalyst Solutions
Jill Wechsler Regulatory Watch Jill Wechsler Global Expansion Shapes Drug Oversight
Chris Burgess Statistical Solutions Chris BurgessIs a Sample Size of n=6 a Magic Number?
Sean Milmo European Regulatory WatchSean MilmoRegulating the Environmental Impact of Pharmaceuticals
Click here